Under the agreement, Gavi and Moderna agree to cancel the remaining volumes under their previous agreement in 2022 and establish a framework for lower-income countries to access doses of variant-containing vaccine (VCV) beginning in 2023. Gavi will have the right to access up to 100 million VCV doses, at Moderna’s lowest-tiered price, on behalf of AMC participants.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/GVkdqsU
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Gavi, Moderna ink agreement on access to variant-containing vaccines for lower-income countries
https://ift.tt/hO1fj5X
No comments:
Post a Comment